Fierce Pharma September 6, 2024
Astellas is closing a gene therapy manufacturing facility in South San Francisco. But, across the country, the company opened a new R&D center in Massachusetts. Chinese authorities detained several current or former AstraZeneca employees. And more.
1. Astellas Gene Therapies to turn out the lights at South San Francisco production plant
Astellas’ gene therapy branch is closing its Eccles manufacturing facility in South San Francisco. All existing programs at the plant will be moved to another site in Sanford, North Carolina. While the fate of the California site’s 100 employees wasn’t immediately clear, at least 17 staffers are being let go, according to two public notices.
2. Astellas unveils Massachusetts lab that will be shared with biotechs, academia researchers
Astellas...
Today's Sponsors
Today's Sponsor